IMMERSION CORPORATION (IMMR) Fundamental Analysis & Valuation

NASDAQ:IMMR • US4525211078

Current stock price

5.6 USD
+0.01 (+0.18%)
At close:
5.6 USD
0 (0%)
After Hours:

This IMMR fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. IMMR Profitability Analysis

1.1 Basic Checks

  • IMMR had positive earnings in the past year.
  • In the past year IMMR has reported a negative cash flow from operations.
  • Each year in the past 5 years IMMR has been profitable.
  • Of the past 5 years IMMR 4 years had a positive operating cash flow.
IMMR Yearly Net Income VS EBIT VS OCF VS FCFIMMR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M 100M

1.2 Ratios

  • IMMR's Return On Assets of 2.46% is fine compared to the rest of the industry. IMMR outperforms 67.57% of its industry peers.
  • IMMR has a better Return On Equity (10.48%) than 78.38% of its industry peers.
  • IMMR's Return On Invested Capital of 6.09% is fine compared to the rest of the industry. IMMR outperforms 67.57% of its industry peers.
Industry RankSector Rank
ROA 2.46%
ROE 10.48%
ROIC 6.09%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
IMMR Yearly ROA, ROE, ROICIMMR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -100 -200 -300 -400

1.3 Margins

  • With a decent Profit Margin value of 1.86%, IMMR is doing good in the industry, outperforming 64.86% of the companies in the same industry.
  • IMMR's Profit Margin has declined in the last couple of years.
  • Looking at the Operating Margin, with a value of 4.20%, IMMR is in the better half of the industry, outperforming 67.57% of the companies in the same industry.
  • IMMR's Operating Margin has declined in the last couple of years.
  • IMMR's Gross Margin of 24.66% is in line compared to the rest of the industry. IMMR outperforms 43.24% of its industry peers.
  • In the last couple of years the Gross Margin of IMMR has declined.
Industry RankSector Rank
OM 4.2%
PM (TTM) 1.86%
GM 24.66%
OM growth 3Y-46.73%
OM growth 5YN/A
PM growth 3Y-51.63%
PM growth 5YN/A
GM growth 3Y-34.72%
GM growth 5Y-22.53%
IMMR Yearly Profit, Operating, Gross MarginsIMMR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50 100 -100

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. IMMR Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), IMMR is destroying value.
  • IMMR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
IMMR Yearly Shares OutstandingIMMR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
IMMR Yearly Total Debt VS Total AssetsIMMR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.2 Solvency

  • IMMR has an Altman-Z score of 2.07. This is not the best score and indicates that IMMR is in the grey zone with still only limited risk for bankruptcy at the moment.
  • IMMR has a Altman-Z score of 2.07. This is comparable to the rest of the industry: IMMR outperforms 51.35% of its industry peers.
  • A Debt/Equity ratio of 0.57 indicates that IMMR is somewhat dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.57, IMMR is in line with its industry, outperforming 48.65% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.57
Debt/FCF N/A
Altman-Z 2.07
ROIC/WACC0.68
WACC8.95%
IMMR Yearly LT Debt VS Equity VS FCFIMMR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M 100M 150M

2.3 Liquidity

  • IMMR has a Current Ratio of 2.23. This indicates that IMMR is financially healthy and has no problem in meeting its short term obligations.
  • The Current ratio of IMMR (2.23) is better than 64.86% of its industry peers.
  • A Quick Ratio of 1.08 indicates that IMMR should not have too much problems paying its short term obligations.
  • The Quick ratio of IMMR (1.08) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 2.23
Quick Ratio 1.08
IMMR Yearly Current Assets VS Current LiabilitesIMMR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. IMMR Growth Analysis

3.1 Past

  • The earnings per share for IMMR have decreased strongly by -60.03% in the last year.
  • Measured over the past years, IMMR shows a very strong growth in Earnings Per Share. The EPS has been growing by 69.05% on average per year.
  • Looking at the last year, IMMR shows a very strong growth in Revenue. The Revenue has grown by 95.11%.
  • The Revenue has been growing by 112.39% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-60.03%
EPS 3Y69.05%
EPS 5YN/A
EPS Q2Q%-103.45%
Revenue 1Y (TTM)95.11%
Revenue growth 3Y253.94%
Revenue growth 5Y112.39%
Sales Q2Q%59.16%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-48.14%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year1.86%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
IMMR Yearly Revenue VS EstimatesIMMR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 500M 1B 1.5B
IMMR Yearly EPS VS EstimatesIMMR Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 1 2 3

More info and screens

Find the best growth stocksShow best growing peers

6

4. IMMR Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 6.02 indicates a rather cheap valuation of IMMR.
  • Based on the Price/Earnings ratio, IMMR is valued cheaply inside the industry as 97.30% of the companies are valued more expensively.
  • When comparing the Price/Earnings ratio of IMMR to the average of the S&P500 Index (27.18), we can say IMMR is valued rather cheaply.
  • The Price/Forward Earnings ratio is 3.29, which indicates a rather cheap valuation of IMMR.
  • IMMR's Price/Forward Earnings ratio is rather cheap when compared to the industry. IMMR is cheaper than 97.30% of the companies in the same industry.
  • IMMR's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 37.96.
Industry RankSector Rank
PE 6.02
Fwd PE 3.29
IMMR Price Earnings VS Forward Price EarningsIMMR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • 100.00% of the companies in the same industry are more expensive than IMMR, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 0.96
IMMR Per share dataIMMR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40 50

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

5

5. IMMR Dividend Analysis

5.1 Amount

  • IMMR has a Yearly Dividend Yield of 4.23%, which is a nice return.
  • Compared to an average industry Dividend Yield of 0.75, IMMR pays a better dividend. On top of this IMMR pays more dividend than 94.59% of the companies listed in the same industry.
  • IMMR's Dividend Yield is rather good when compared to the S&P500 average which is at 1.82.
Industry RankSector Rank
Dividend Yield 4.23%

5.2 History

  • IMMR has paid a dividend for less than 5 years, so there is no long track record yet.
Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years1
IMMR Yearly Dividends per shareIMMR Yearly Dividends per shareYearly Dividends per share 2023 2024 2025 2026 0.1 0.2 0.3

5.3 Sustainability

  • IMMR pays out 31.81% of its income as dividend. This is a sustainable payout ratio.
DP31.81%
EPS Next 2YN/A
EPS Next 3YN/A
IMMR Yearly Income VS Free CF VS DividendIMMR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M -20M 40M -40M 60M -60M
IMMR Dividend Payout.IMMR Dividend Payout, showing the Payout Ratio.IMMR Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

IMMR Fundamentals: All Metrics, Ratios and Statistics

IMMERSION CORPORATION

NASDAQ:IMMR (4/13/2026, 8:00:02 PM)

After market: 5.6 0 (0%)

5.6

+0.01 (+0.18%)

Chartmill FA Rating
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryTechnology Hardware, Storage & Peripherals
Earnings (Last)10-01
Earnings (Next)N/A
Inst Owners54.53%
Inst Owner Change0%
Ins Owners4.92%
Ins Owner Change6.07%
Market Cap184.35M
Revenue(TTM)1.66B
Net Income(TTM)31.00M
Analysts82.86
Price Target13.77 (145.89%)
Short Float %13.77%
Short Ratio9.79
Dividend
Industry RankSector Rank
Dividend Yield 4.23%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP31.81%
Div Incr Years1
Div Non Decr Years1
Ex-Date04-20
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)67.33%
Min Revenue beat(2)11.72%
Max Revenue beat(2)122.94%
Revenue beat(4)4
Avg Revenue beat(4)153.37%
Min Revenue beat(4)3.43%
Max Revenue beat(4)475.4%
Revenue beat(8)7
Avg Revenue beat(8)193.99%
Revenue beat(12)9
Avg Revenue beat(12)127.73%
Revenue beat(16)10
Avg Revenue beat(16)97.05%
PT rev (1m)0%
PT rev (3m)10.2%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 6.02
Fwd PE 3.29
P/S 0.11
P/FCF N/A
P/OCF N/A
P/B 0.62
P/tB 1.36
EV/EBITDA 0.96
EPS(TTM)0.93
EY16.61%
EPS(NY)1.7
Fwd EY30.42%
FCF(TTM)-2.35
FCFYN/A
OCF(TTM)-1.92
OCFYN/A
SpS50.56
BVpS8.99
TBVpS4.13
PEG (NY)N/A
PEG (5Y)N/A
Graham Number13.71
Profitability
Industry RankSector Rank
ROA 2.46%
ROE 10.48%
ROCE 7.73%
ROIC 6.09%
ROICexc 7.48%
ROICexgc 9.55%
OM 4.2%
PM (TTM) 1.86%
GM 24.66%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-46.73%
OM growth 5YN/A
PM growth 3Y-51.63%
PM growth 5YN/A
GM growth 3Y-34.72%
GM growth 5Y-22.53%
F-Score4
Asset Turnover1.32
Health
Industry RankSector Rank
Debt/Equity 0.57
Debt/FCF N/A
Debt/EBITDA 1.5
Cap/Depr 32.23%
Cap/Sales 0.84%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.23
Quick Ratio 1.08
Altman-Z 2.07
F-Score4
WACC8.95%
ROIC/WACC0.68
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-60.03%
EPS 3Y69.05%
EPS 5YN/A
EPS Q2Q%-103.45%
EPS Next Y-48.14%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)95.11%
Revenue growth 3Y253.94%
Revenue growth 5Y112.39%
Sales Q2Q%59.16%
Revenue Next Year1.86%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-32.9%
EBIT growth 3Y88.53%
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-1114.58%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-892.18%
OCF growth 3YN/A
OCF growth 5YN/A

IMMERSION CORPORATION / IMMR Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for IMMERSION CORPORATION?

ChartMill assigns a fundamental rating of 4 / 10 to IMMR.


What is the valuation status for IMMR stock?

ChartMill assigns a valuation rating of 6 / 10 to IMMERSION CORPORATION (IMMR). This can be considered as Fairly Valued.


Can you provide the profitability details for IMMERSION CORPORATION?

IMMERSION CORPORATION (IMMR) has a profitability rating of 4 / 10.


Can you provide the PE and PB ratios for IMMR stock?

The Price/Earnings (PE) ratio for IMMERSION CORPORATION (IMMR) is 6.02 and the Price/Book (PB) ratio is 0.62.


How financially healthy is IMMERSION CORPORATION?

The financial health rating of IMMERSION CORPORATION (IMMR) is 4 / 10.